Sierra Oncology Reports Favorable Long-Term Safety and Dose Intensity Data for Momelotinib

- Data presented at the 25th European Hematology Association (EHA) Virtual Congress further demonstrate the potential anemia benefits and favorable hematological safety profile of momelotinib - - Long-term tolerability facilitates sustained dose intensity and prolonged clinical activity;...

from PR Newswire: https://ift.tt/2MMZNiC